BISPROLOL PFIZER 1.25 Milligram Film Coated Tablet
Country: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
পণ্য বৈশিষ্ট্য
(SPC)
23-04-2024
এই পণ্যটির জন্য কিছু নথি বর্তমানে উপলভ্য নয়, আপনি আমাদের গ্রাহক পরিষেবায় একটি অনুরোধ প্রেরণ করতে পারেন এবং আমরা তা পাওয়ার সাথে সাথে আপনাকে তা জানাব।
অনুরোধ প্রেরণ করুন।
অনুরোধ প্রেরণ করুন।
সক্রিয় উপাদান:
BISOPROLOL FUMARATE
থেকে পাওয়া:
Pfizer Healthcare Ireland
INN (International Name):
BISOPROLOL FUMARATE
ডোজ:
1.25 Milligram
ফার্মাসিউটিকাল ফর্ম:
Film Coated Tablet
প্রেসক্রিপশন টাইপ:
Product subject to prescription which may be renewed (B)
অনুমোদন অবস্থা:
Withdrawn
অনুমোদন তারিখ:
2012-04-26
পণ্য বৈশিষ্ট্য
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Bisoprolol Pfizer 1.25mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains 1.25 mg bisoprolol fumarate equivalent to 1.06 mg bisoprolol.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet
White, circular, biconvex, film-coated tablets, 5.2 mm in diameter, debossed with ‘P’ on one side and ‘1’ on the other
side.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors,
and diuretics, and optionally cardiac glycosides (For additional information see section 5.1).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_Method of administration_
Bisoprolol tablets should be taken in the morning and can be taken with food. They should be swallowed with liquid
and should not be chewed.
Treatment of stable chronic heart failure
Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in case of intolerance to
ACE inhibitors), a beta-blocking agent, diuretics, and when appropriate cardiac glycosides. Patients should be stable
(without acute failure) when bisoprolol treatment is initiated.
It is recommended that the treating physician should be experienced in the management of chronic heart failure.
Transient worsening of heart failure, hypotension, or bradycardia may occur during the titration period and thereafter.
Titration phase
The treatment of stable chronic heart failure with bisoprolol requires a titration phase.
The treatment with bisoprolol is to be started with a gradual up titration according to the following steps:
1.25 mg once daily for 1 week, if well tolerated increase to
2.5 mg once
সম্পূর্ণ নথি পড়ুন
